A phase III, randomized, multi-center, double blind, placebo controlled study of safety and efficacy of Lofexidine for relief of symptoms in individuals undergoing inpatient opioid withdrawal Original source: A phase III, randomized, multi-center, double blind, placebo controlled study of safety and efficacy of Lofexidine for relief of symptoms in individuals undergoing inpatient opioid withdrawal